Medical Device
Manufacturing
THE TRADE PAPER OF THE FACTORY FLOOR
K200926Substantially Equivalent

OrthoGold 100

Tissue Regeneration Technologies, Woodstock GA / Traditional, Substantially Equivalent

K200926 is the FDA 510(k) clearance record for OrthoGold 100, a class II device, cleared for Tissue Regeneration Technologies, LLC on under FDA product code PZL (Extracorporeal Shock Wave Device For Treatment Of Diabetic Foot Ulcers). FDA's definition for product code PZL reads: "Treatment of diabetic foot ulcers". FDA records list 5 510(k) clearances for Tissue Regeneration Technologies, LLC, from to . As of , FDA records show no recalls naming K200926.

Clearance record

Decision date
Received
(143 days to decision)
Product code
PZL Extracorporeal Shock Wave Device For Treatment Of Diabetic Foot Ulcers
Regulation
21 CFR 878.4685
Device class
Class II
Review panel
General, Plastic Surgery
Applicant
Tissue Regeneration Technologies, LLC 251 Heritage Walk, Woodstock GA
510(k) summary
Summary PDF
Third party review
No

Clearances, product code PZL

Trailing 12 months

FDA records hold no clearances under product code PZL in the trailing twelve months.

FDA records show no clearances under product code PZL in the twelve months to October 2026.
Show the numbers
Monthly 510(k) clearances under FDA product code PZL, trailing twelve months
MonthClearances
November 20250
December 20250
January 20260
February 20260
March 20260
April 20260
May 20260
June 20260
July 20260
August 20260
September 20260
October 20260